Century Therapeutics, Inc. 8-K
Accession 0001104659-26-002748
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 9:05 AM ET
Size
7.1 MB
Accession
0001104659-26-002748
Research Summary
AI-generated summary of this filing
Century Therapeutics Updates Investor Presentation (Files 8‑K)
What Happened
Century Therapeutics, Inc. (IPSC) filed a Form 8‑K on January 12, 2026 (Item 7.01) to disclose that it updated the information in its investor slide presentation. The updated presentation is attached as Exhibit 99.1 to the 8‑K and company representatives will use the revised slides in meetings with investors going forward. The filing also notes this disclosure is made under Regulation FD.
Key Details
- Filing date: January 12, 2026 (Form 8‑K, Item 7.01).
- Exhibit included: Investor Presentation dated January 12, 2026 (Exhibit 99.1).
- Use: Updated slides will be used in various investor meetings.
- Regulatory note: The material in the 8‑K/Exhibit 99.1 is not deemed “filed” for Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings.
Why It Matters
An updated investor presentation can provide the company’s latest messaging, program highlights or operational data to investors and analysts. Because the company explicitly states the slides are not “filed” or incorporated by reference, investors should review Exhibit 99.1 directly for any new information, while understanding it does not carry the same legal filing status as formal SEC-reported financial statements.
Documents
- 8-Ktm262422d3_8k.htmPrimary
FORM 8-K
- EX-99.1tm262422d3_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHipsc-20260112.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABipsc-20260112_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREipsc-20260112_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICtm262422d3_ex99-1img001.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img002.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img003.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img004.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img005.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img006.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img007.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img008.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img009.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img010.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img011.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img012.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img013.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img014.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img015.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img016.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img017.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img018.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img019.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img020.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img021.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img022.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img023.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img024.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img025.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img026.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img027.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img028.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img029.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img030.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img031.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img032.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img033.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img034.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img035.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img036.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img037.jpg
GRAPHIC
- GRAPHICtm262422d3_ex99-1img038.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-26-002748-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLtm262422d3_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Related Parties
1- filerCIK 0001850119
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 9:05 AM ET
- Size
- 7.1 MB